Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Reactive oxygen species (ROS) are critical mediators in many physiological processes including innate and adaptive immunity, making the modulation of ROS level a powerful strategy to augment anticancer immunity. However, current evidences suggest the necessity of a deeper understanding of their mult...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jie Wang, Ning Liu, Hongfei Jiang, Qian Li, Dongming Xing
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
ROS
Acceso en línea:https://doaj.org/article/f210d43dd16945698f52750385c345af
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f210d43dd16945698f52750385c345af
record_format dspace
spelling oai:doaj.org-article:f210d43dd16945698f52750385c345af2021-11-17T07:03:17ZReactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword2296-418510.3389/fbioe.2021.784612https://doaj.org/article/f210d43dd16945698f52750385c345af2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fbioe.2021.784612/fullhttps://doaj.org/toc/2296-4185Reactive oxygen species (ROS) are critical mediators in many physiological processes including innate and adaptive immunity, making the modulation of ROS level a powerful strategy to augment anticancer immunity. However, current evidences suggest the necessity of a deeper understanding of their multiple roles, which may vary with their concentration, location and the immune microenvironment they are in. Here, we have reviewed the reported effects of ROS on macrophage polarization, immune checkpoint blocking (ICB) therapy, T cell activation and expansion, as well as the induction of immunogenic cell death. A majority of reports are indicating detrimental effects of ROS, but it is unadvisable to simply scavenge them because of their pleiotropic effects in most occasions (except in T cell activation and expansion where ROS are generally undesirable). Therefore, clinical success will need a clearer illustration of their multi-faced functions, as well as more advanced technologies to tune ROS level with high spatiotemporal control and species-specificity. With such progresses, the efficacy of current immunotherapies will be greatly improved by combining with ROS-targeted therapies.Jie WangJie WangNing LiuHongfei JiangHongfei JiangQian LiDongming XingDongming XingDongming XingFrontiers Media S.A.articleROSimmunotherapymacrophage polarizationT cell activationimmunogenic cell deathBiotechnologyTP248.13-248.65ENFrontiers in Bioengineering and Biotechnology, Vol 9 (2021)
institution DOAJ
collection DOAJ
language EN
topic ROS
immunotherapy
macrophage polarization
T cell activation
immunogenic cell death
Biotechnology
TP248.13-248.65
spellingShingle ROS
immunotherapy
macrophage polarization
T cell activation
immunogenic cell death
Biotechnology
TP248.13-248.65
Jie Wang
Jie Wang
Ning Liu
Hongfei Jiang
Hongfei Jiang
Qian Li
Dongming Xing
Dongming Xing
Dongming Xing
Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
description Reactive oxygen species (ROS) are critical mediators in many physiological processes including innate and adaptive immunity, making the modulation of ROS level a powerful strategy to augment anticancer immunity. However, current evidences suggest the necessity of a deeper understanding of their multiple roles, which may vary with their concentration, location and the immune microenvironment they are in. Here, we have reviewed the reported effects of ROS on macrophage polarization, immune checkpoint blocking (ICB) therapy, T cell activation and expansion, as well as the induction of immunogenic cell death. A majority of reports are indicating detrimental effects of ROS, but it is unadvisable to simply scavenge them because of their pleiotropic effects in most occasions (except in T cell activation and expansion where ROS are generally undesirable). Therefore, clinical success will need a clearer illustration of their multi-faced functions, as well as more advanced technologies to tune ROS level with high spatiotemporal control and species-specificity. With such progresses, the efficacy of current immunotherapies will be greatly improved by combining with ROS-targeted therapies.
format article
author Jie Wang
Jie Wang
Ning Liu
Hongfei Jiang
Hongfei Jiang
Qian Li
Dongming Xing
Dongming Xing
Dongming Xing
author_facet Jie Wang
Jie Wang
Ning Liu
Hongfei Jiang
Hongfei Jiang
Qian Li
Dongming Xing
Dongming Xing
Dongming Xing
author_sort Jie Wang
title Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
title_short Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
title_full Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
title_fullStr Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
title_full_unstemmed Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword
title_sort reactive oxygen species in anticancer immunity: a double-edged sword
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f210d43dd16945698f52750385c345af
work_keys_str_mv AT jiewang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT jiewang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT ningliu reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT hongfeijiang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT hongfeijiang reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT qianli reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT dongmingxing reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT dongmingxing reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
AT dongmingxing reactiveoxygenspeciesinanticancerimmunityadoubleedgedsword
_version_ 1718425900310069248